The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Are Peptides Safe? What Older Adults Need to Know